Arterra Bioscience
ARBS.MI · MIL
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €13,051 | €11,053 | €14,382 | €19,310 |
| - Cash | €3,343 | €3,686 | €4,393 | €4,814 |
| + Debt | €356 | €386 | €489 | €614 |
| Enterprise Value | €10,064 | €7,753 | €10,479 | €15,110 |
| Revenue | €4,173 | €3,336 | €3,591 | €4,742 |
| % Growth | 25.1% | -7.1% | -24.3% | – |
| Gross Profit | €3,650 | €1,850 | €493 | €673 |
| % Margin | 87.5% | 55.5% | 13.7% | 14.2% |
| EBITDA | €2,042 | €1,844 | €2,337 | €1,767 |
| % Margin | 48.9% | 55.3% | 65.1% | 37.3% |
| Net Income | €1,337 | €1,076 | €1,414 | €1,111 |
| % Margin | 32% | 32.3% | 39.4% | 23.4% |
| EPS Diluted | 0.2 | 0.16 | 0.21 | 0.17 |
| % Growth | 25% | -23.8% | 23.5% | – |
| Operating Cash Flow | €1,064 | €1,026 | €1,395 | €1,397 |
| Capital Expenditures | -€665 | -€83 | -€99 | -€609 |
| Free Cash Flow | €399 | €943 | €1,296 | €788 |